Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of glatiramer acetate in patients with primary progressive Multiple Sclerosis

Trial Profile

Effect of glatiramer acetate in patients with primary progressive Multiple Sclerosis

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Glatiramer acetate (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms PROMiSe
  • Most Recent Events

    • 26 Sep 2022 Results assessing comparing clinical outcomes EDSS, timed 25-foot walk (T25FW), and nine-hole peg test, published in the Journal of Neurology.
    • 28 Apr 2017 Results of reanalysis of PROMiSe trial dataset assessing characteristics and confirmed disability progression (CDP) rates of patients according to cerebrospinal fluid (CSF) status, presented at the 69th Annual Meeting of the American Academy of Neurology
    • 05 Nov 2010 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top